Consumer Health

In 2022, cough, cold and allergy (hay fever) remedies was marked by increases in demand for products to soothe sore throat and cough complaints. This development was a result of extremely high morbidity throughout the year. In the first half of 2022,…

In line with rising health-consciousness, people in Taiwan are becoming more worried about the potentially hazardous side effects and contraindications of active pharmaceutical ingredients in standard OTC medications. This has continued to buoy…

Cough, cold and allergy (hay fever) remedies have witnessed stronger growth in 2023, due to warmer weathers and increased time spent out of the home. Warmer weather in Switzerland has led to an increase in pollen and the incidence of allergic…

Cough, cold and allergy (hay fever) remedies remained the largest product area within consumer health in Sweden in 2023. Following a two-year period of buoyant volume growth for most subcategories, demand weakened significantly in 2023, This was due…

After the surge in sales that cough, cold and allergy (hay fever) remedies experienced in 2022, demand is waning in 2023, with the category recording more subdued growth rates. Traditionally, sales of cough, cold and allergy (hay fever) remedies in…

During the review period, the flu and allergy season in South Africa was rife specifically during the winter periods. Given the presence of several flu strains and allergies, consumers reached out to cough, cold and allergy (hay fever) products to…

Like analgesics, sales of cough, cold and allergy (hay fever) remedies continue to rise, benefiting from the “tripledemic” of rising COVID-19 cases, the stronger return of influenza due to greater mobility outside of the home and contact with others,…

During the past few years, Slovenia has experienced a virtually non-existent flu season due to the outbreak of COVID-19. This led to individuals opting to stay at home and, when going out in public, adhering to practices like wearing face masks,…

In Slovakia, cough, cold and allergy (hay fever) remedies was characterised by very strong increases in retail volume sales of OTC remedies for sore throats, coughs and colds. The high demand was the result of extremely high morbidity throughout the…

The pandemic brought about a huge increase in sales of cough, cold and allergy (hay fever) remedies, especially from the end of 2021, with later COVID-19 variants being revealed to have unique symptoms resembling those of the common cold. In February…

Although the threat from COVID-19 is largely perceived to have past, many consumers continue to worry about how people will react if they sneeze or cough in public. Volume growth of cough, cold and allergy (hay fever) remedies is helping to drive the…

The pandemic has led consumers to become more concerned about the products they consume, and more conscious of side-effects, with some people therefore preferring to purchase herbal/traditional products instead of standard products, or those needing…

Following the return to normality in the wake of the COVID-19 crisis, with no more lockdowns or movement restrictions, there has been an increase in the spread of cold and flu viruses, as well as a widespread rise in issues caused by hay fever and…

During the winters 2020/2021 and 2021/2022, the circulation of cough, cold and flu viruses was limited by the restrictions implemented to contain the COVID-19 pandemic. Winter 2022/2023 was the first one with no restrictions in place at all and this…

The majority of subcategories within cough, cold and allergy remedies recorded positive growth in retail volume terms in 2023. This was due, in a large part, to a return pre-pandemic lifestyles, which facilitated the spread of the influenza virus and…

Consumers have been returning to doctors’ surgeries in the post-pandemic landscape, thus hindering the sales of OTC medicines which they are instead accessing via prescription. This is noted to be the case with antihistamines, for example, along with…

As people become more aware of the importance of self-care, there is a growing demand for OTC medications to treat cough and cold. Access to healthcare is limited and as such it is easier to buy OTC medications. Therefore, despite the increase in…

Cough, cold and allergy (hay fever) remedies remains the largest OTC category in Norway, accounting for more than one-third of total OTC value sales in 2023. Despite the already relatively high penetration of these products, the category registered…

Cough, cold and allergy (hay fever) remedies is seeing slower growth in 2023 due to a shorter cold season caused by milder winter 2022/2023. The exception is antihistamines, which continues to grow at a solid rate due to high consumer demand amidst…

On a landscape featuring local and international brands, consumers can access a wide array of choices. Brands like Emzolyn and Exiplon are popular among individuals with lower disposable incomes, while international counterparts, including Benylin,…